MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial ...
THIS admirable little book is designed to meet the requirements of the elementary examinations of he leading universities of Great Britain, and though of necessity largely concerned with creatures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results